Edition:
United States

Oxford Immunotec Global PLC (OXFD.OQ)

OXFD.OQ on NASDAQ Stock Exchange Global Market

14.01USD
3:59pm EST
Change (% chg)

$0.30 (+2.19%)
Prev Close
$13.71
Open
$13.84
Day's High
$14.08
Day's Low
$13.84
Volume
50,935
Avg. Vol
36,470
52-wk High
$19.50
52-wk Low
$12.20

Latest Key Developments (Source: Significant Developments)

Oxford Immunotec Global Plc says unit entered into a 2nd amendment to purchase agreement with Mabtech AB​
5:06pm EST 

Nov 21 (Reuters) - Oxford Immunotec Global Plc :Oxford Immunotec Global Plc - ‍on Nov 17, unit entered into a second amendment to purchase agreement with Mabtech AB​.Oxford Immunotec Global says ‍second amendment extends term of agreement until December 31, 2023 & establishes pricing - SEC Filing​.  Full Article

Oxford Immunotec Global Q3 loss per share $0.70
Tuesday, 31 Oct 2017 07:00am EDT 

Oct 31 (Reuters) - Oxford Immunotec Global Plc :Oxford Immunotec reports third quarter 2017 financial results.Q3 loss per share $0.70.Sees Q4 2017 revenue $25.4 million to $26.4 million.Q3 revenue $30.4 million versus I/B/E/S view $30 million.Q3 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S.Sees FY 2017 revenue $103.5 million to $104.5 million.FY2017 revenue view $104.6 million -- Thomson Reuters I/B/E/S.  Full Article

Oxford Immunotec Global Plc announces pricing of underwritten public offering of ordinary shares
Tuesday, 15 Aug 2017 09:00am EDT 

Aug 15 (Reuters) - Oxford Immunotec Global Plc :Oxford Immunotec Global Plc announces pricing of underwritten public offering of ordinary shares.Oxford Immunotec Global Plc - ‍pricing of its previously announced underwritten public offering of 2.5 million ordinary shares​.Oxford Immunotec Global Plc - ‍aggregate gross proceeds from offering to Oxford Immunotec will be $40.125 million​.  Full Article

Oxford Immunotec Global announces agreement to sell 2.5 mln ordinary shares
Monday, 14 Aug 2017 04:20pm EDT 

Aug 14 (Reuters) - Oxford Immunotec Global Plc :Oxford Immunotec Global Plc announces agreement to sell 2,500,000 ordinary shares.Oxford Immunotec Global Plc - ‍ agreement to sell 2.5 million ordinary shares to Btig, Llc as underwriter in an underwritten public offering​.Oxford Immunotec Global Plc - ‍oxford immunotec intends to use net proceeds from offering for working capital and general corporate purposes​.  Full Article

Oxford Immunotec Q2 loss per share $0.74
Tuesday, 1 Aug 2017 07:00am EDT 

Aug 1 (Reuters) - Oxford Immunotec Global Plc :Oxford immunotec reports second quarter 2017 financial results.Q2 loss per share $0.74.Sees q3 2017 revenue $29.5 million to $30.5 million.Q2 revenue $26.1 million versus i/b/e/s view $25 million.Q2 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S.Sees fy 2017 revenue $103 million to $106 million.  Full Article

Oxford Immunotec Global says unit entered into amendment to marketing authorization holder agreement with Riken Genesis
Friday, 28 Jul 2017 04:52pm EDT 

July 28 (Reuters) - Oxford Immunotec Global Plc ::Oxford Immunotec Global Plc - on july 24, unit of co entered into amendment to marketing authorization holder agreement with Riken Genesis Co., Ltd.Oxford Immunotec Global Plc - amendment amends marketing authorization holder agreement between parties dated july 29, 2011, as amended april 1, 2016.Oxford Immunotec Global Plc - amendment modifies termination provision of agreement and memorializes monthly retainer applicable to services.  Full Article

Oxford Immunotec posts Q1 loss per share of $0.36
Tuesday, 2 May 2017 07:00am EDT 

May 2 (Reuters) - Oxford Immunotec Global Plc :Q2 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $-1.03 -- Thomson Reuters I/B/E/S.Reports first quarter 2017 financial results.Q1 loss per share $0.36.Sees q2 2017 revenue $24.9 million to $25.7 million.Q1 revenue $21.5 million versus i/b/e/s view $21.2 million.Q1 earnings per share view $-0.35 -- Thomson Reuters I/B/E/S.Sees fy 2017 revenue $102 million to $105 million.Expect revenue to increase 21% to 24% for year using constant exchange rates.  Full Article

Oxford Immunotec Q4 loss per share $0.22
Tuesday, 28 Feb 2017 04:05pm EST 

Oxford Immunotec Global Plc : Oxford immunotec reports fourth quarter and full year 2016 financial results . Q4 loss per share $0.22 . Sees q1 2017 revenue $20.8 million to $21.3 million . Q4 revenue $23.7 million versus i/b/e/s view $22.9 million . Sees fy 2017 revenue $102 million to $105 million . Q4 earnings per share view $-0.39 -- Thomson Reuters I/B/E/S . Fy2017 revenue view $105.1 million -- Thomson Reuters I/B/E/S .Q1 revenue view $22.6 million -- Thomson Reuters I/B/E/S.  Full Article

Oxford Immunotec Global files for a mixed shelf of up to $150 mln
Wednesday, 21 Dec 2016 05:48pm EST 

Oxford Immunotec Global Plc :Oxford Immunotec Global Plc - files for a mixed shelf of up to $150 million - SEC filing.  Full Article

Oxford Immunotec announces New England Journal of Medicine Publication on clinical trial results of serological and nucleic acid tests for babesia in blood screening
Thursday, 8 Dec 2016 07:00am EST 

Oxford Immunotec Global Plc :Oxford Immunotec announces New England Journal of Medicine Publication on clinical trial results of serological and nucleic acid tests for babesia in blood screening.  Full Article

BRIEF-Oxford Immunotec Global Plc says unit entered into a 2nd amendment to purchase agreement with Mabtech AB​

* Oxford Immunotec Global Plc - ‍on Nov 17, unit entered into a second amendment to purchase agreement with Mabtech AB​